In a paper published in the Journal of Biological Chemistry, a team from UNC Lineberger Comprehensive Cancer Center has narrowed the focus of this scientific quest to a protein called RGL2.
The company, G-Zero Therapeutics, is commercializing a high potential marker of molecular age measured from a patient blood sample, which could assist physicians in making more informed treatment-management decisions.
The five-year, $3.9 million grant will be used to target 13 North Carolina counties through the Carolina Community Network to Reduce Cancer Health Disparities.
The National Cancer Institute (NCI) has awarded one of two Comprehensive Minority Institution Cancer Center Partnership Grants in the nation to North Carolina Central University (NCCU) and the University of North Carolina at Chapel Hill and its UNC Lineberger Comprehensive Cancer Center.
An uncommon but serious bone marrow disorder sends mortgage banker Gwen Tyson of Kitty Hawk, N.C., to UNC Hospitals for two bone marrow transplants. Slowly, Tyson’s blood counts are rising, and she looks forward to being back on her bicycle pedaling 14 miles at daybreak.
In a study published in the journal Urologic Oncology, researchers showed that a multidisciplinary approach changed the initial diagnosis or treatment recommendations in almost 65 percent of cases.
Scientists at the University of North Carolina at Chapel Hill School of Medicine have reported the exact molecular structure and mechanisms of a major cell signaling pathway that serves a broad range of functions in humans.
The $1.5 million grant will fund Dr. Ben Major's work to address a significant medical science challenge: identifying the full complement of genes that functionally contribute to specific cellular and disease processes such as cancer.
Researchers from the University of North Carolina at Chapel Hill School of Medicine have received over $1.6 million in research awards from the Department of Defense to fund two separate studies, one on post-traumatic stress syndrome and the other on breast cancer stem cells.
UNC scientists receive grant to develop nanotechnology for pancreatic cancer diagnosis and treatment
A team of UNC scientists has received a five-year $2,308,800 grant from the National Cancer Institute’s Cancer Nanotechnology Platform Partnerships to address the critical need for early diagnosis of and more effective treatments for pancreatic cancer.
National Cancer Institute awards $13.6 million to UNC's Carolina Center of Cancer Nanotechnology Excellence
The grant will support the continued work of the center launched in 2005 as part of NCI’s Alliance for Nanotechnology in Cancer. The C-CCNE, one of eight original centers in the national program, is one of nine that are funded in the new phase.
A conference on understanding bladder cancer, hosted by UNC with the Bladder Cancer Advocacy Network (BCAN), has led to the formation of a new support group for patients in the Triangle.
Community partners have turned out in force to help UNC Lineberger "Turn the Town Pink" to benefit UNC’s Comprehensive Cancer Support Program (CCSP). More than 40 community partners have committed to turning the town pink – through store displays, special events and promotions.
The UNC Comprehensive Cancer Support Program (CCSP) is offering an educational series for single fathers facing the challenges of raising children following the loss of their wives to cancer.
Their findings could lead to a better understanding of how the protein works and how BRCA2 sequence mutations cause cancer.
These contracts, called Task Orders, were awarded in support of the NCI’s Chemical Biology Consortium (CBC) program, and provide funding to one-year and 18-month milestones respectively.
This weekend, Dr. Richard Goldberg, Physician-in-Chief at the NC Cancer Hospital, will join YOUR HEALTH Radio to talk about cancer care and research. This is the conclusion of our cancer series with experts from the NC Cancer Hospital and the UNC Lineberger Comprehensive Cancer Center.
The American College of Radiology has designated UNC’s Breast Imaging Center a Center of Excellence.
This weekend, Dr. Linda Van Le, acting division director for the UNC Division of Gynecologic Oncology, will join YOUR HEALTH Radio to talk about the women and cancer.
The Division of Hematology and Oncology began a new service on July 1, 2010 because, as we hoped, the new N.C. Cancer Hospital facilities and our growing reputation for excellence in cancer care is attracting more patients.